Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Kazia Therapeutics.
RELATED STOCKHEAD STORIES
Health & Biotech
Here are the ASX stocks chipper about Bill Shorten’s $2.3 billion cancer funding pledge
Health & Biotech
Tailoring medicine to our DNA could save our health system billions – let’s get personal
Health & Biotech
Fliers, flameouts and fakers: what happened in biotechland in 2018
Health & Biotech